Yu, Z., Gao, L., Zang, Y., Cheng, L., Gao, W., & Xu, Y. (2024). Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real‐world finding. Wiley.
Chicago Style (17th ed.) CitationYu, Zhe, Ling Gao, Yinshan Zang, Lu Cheng, Wenjia Gao, and Yan Xu. Adalimumab Exhibits Superiority over Etanercept in Terms of a Numerically Higher Response Rate and Equivalent Adverse Events: A Real‐world Finding. Wiley, 2024.
MLA (9th ed.) CitationYu, Zhe, et al. Adalimumab Exhibits Superiority over Etanercept in Terms of a Numerically Higher Response Rate and Equivalent Adverse Events: A Real‐world Finding. Wiley, 2024.
Warning: These citations may not always be 100% accurate.